During apoptosis the mitochondrial network fragments. Using short hairpin RNAs (shRNAs) for RNA interference (RNAi) we manipulated the expression levels of three proteins, hFis1, Drp1 and Opa1, that are involved in mitochondrial fission and fusion in mammalian cells, and we characterized their functions in mitochondrial morphology and apoptosis. Down-regulation of hFis1 powerfully inhibits cell death to an extent significantly greater than down-regulation of Drp1 and at a stage of apoptosis distinct from that induced by Drp1 inhibition. Cells depleted of Opa1 are extremely sensitive to exogenous apoptosis induction and some die spontaneously by a process that requires hFis1 expression. Wild-type Opa1 may function normally as an antiapoptotic protein, keeping spontaneous apoptosis in check. However, if hFis1 is down-regulated, cells do not require Opa1 to prevent apoptosis, suggesting that Opa1 may be normally counteracting the pro-apoptotic action of hFis1. We also demonstrate in this study that mitochondrial fragmentation per se does not result in apoptosis. However, we provide further evidence that multiple components of the mitochondrial morphogenesis machinery can positively and negatively regulate apoptosis.
Introduction
Mitochondria are morphologically dynamic organelles that continuously divide and fuse to form small individual units or interconnected networks within the cell (Bereiter-Hahn, 1990 ).
They reach an equilibrium between these two states in healthy cells by regulating the relative rates of organelle fusion and fission (Nunnari et al., 1997) . Proteins controlling mitochondrial fission include Drp1 (DNM1 in yeast) (Otsuga et al., 1998; Bleazard et al., 1999) , Fis1 (Mozdy et al., 2000; Jakobs et al., 2003) and up to 6 other gene products in yeast (Dimmer et al., 2002) .
Drp1 is a large GTPase similar to dynamin, a protein that spirals around the necks of endocytic vesicles and facilitates their scission from the plasma membrane (Hinshaw, 2000) . Inhibition of Drp1 GTPase activity with a dominant negative protein defective in GTP binding (Drp1   K38A   ) results in elongated mitochondria, confirming that in mammalian cells (Smirnova et al., 1998; Frank et al., 2001; Smirnova et al., 2001 ) Drp1 functions like its yeast ortholog, DNM1, in mitochondrial fission (Otsuga et al., 1998; Bleazard et al., 1999) . Drp1 exists primarily in the cytoplasm but partially associates into foci on the outer surface of mitochondria that coalesce at sites of organelle fission (Smirnova et al., 2001) . Human Fis1 (hFis1) contains a TPR motif domain (Suzuki et al., 2003; Dohm et al., 2004) facing the cytoplasm and is anchored in the outer mitochondrial membrane via a C-terminal hydrophobic tail (Yoon et al., 2003) . hFis1 circumscribes the outer surface of mitochondria and is not localized specifically to mitochondrial scission sites (Suzuki et al., 2003; Yoon et al., 2003) . Down-regulating mammalian Fis1 expression by RNAi induces mitochondrial elongation (Stojanovski et al., 2004) confirming results previously reported in yeast that FIS1 is involved in mitochondrial fission (Mozdy et al., 2000; Jakobs et al., 2003) .
Mitochondrial fusion in mammalian cells is controlled by the large GTPases, Mfn1 (Santel and Fuller, 2001; Ishihara et al., 2003) , Mfn2 (Santel and Fuller, 2001; Ishihara et al., 2003) and Opa1 (MGM1 in yeast) (Olichon et al., 2002; Satoh et al., 2003) . Elimination of any of these proteins induces mitochondrial fragmentation (Chen et al., 2003; Olichon et al., 2003; Griparic et al., 2004) . Mutations in Opa1 were found to cause dominant optic atrophy (Alexander et al., 2000; Delettre et al., 2000) potentially connecting this process (inhibition of mitochondrial fusion) to human disease.
During apoptosis the mitochondrial network fragments, resulting in smaller and more numerous mitochondria (Mancini et al., 1997; De Vos et al., 1998; Zhuang et al., 1998; Desagher et al., 1999; Frank et al., 2001; Karbowski et al., 2002) . It has been reported that increased fission, decreased fusion or both cause this mitochondrial phenotype at a stage of apoptosis upstream of caspase activation and close to that of Bax translocation to mitochondria and cytochrome c release (Karbowski et al., 2004) , suggesting a mechanistic link between mitochondrial morphology and apoptosis. Drp1 binding to mitochondria is increased during apoptosis (Frank et al., 2001; Breckenridge et al., 2003) and the Drp1 foci at mitochondrial scission sites colocalize with foci of Bax that occur on mitochondria during apoptosis (Karbowski et al., 2002) . Inhibition of Drp1 GTPase activity with a dominant negative protein (Drp1 K38A ) prevents the mitochondrial fragmentation seen during apoptosis and delays the process of cell death (Frank et al., 2001; Karbowski et al., 2002) suggesting that mitochondrial fission is a required step in apoptosis. Over-expression of hFis1 has been reported to induce apoptosis (James et al., 2003) , also suggesting the involvement of mitochondrial fission in 5 apoptosis. Down regulation of Opa1 expression in cells by RNAi results in spontaneous cell apoptosis (Olichon et al., 2003) suggesting that the promotion of mitochondrial fusion by wild type levels of Opa1 normally protects cells from apoptosis.
To further investigate the link between mitochondrial fission and apoptosis we have explored the role of hFis1 in these processes. Using short hairpin RNAs (shRNAs) for RNA interference (RNAi) (Paddison et al., 2002) we have down-regulated three proteins involved in mitochondrial morphology: Drp1, hFis1, and Opa1. Using this technique we are able to manipulate the expression levels of the proteins, and characterize their functions in mitochondrial morphology and apoptosis. Down-regulation of hFis1 powerfully inhibits cell death by multiple pathways to an extent significantly greater than down-regulation of Drp1 and at a stage of apoptosis distinct from that induced by Drp1 inhibition. Cells depleted of Opa1 are extremely sensitive to exogenous apoptosis induction and spontaneously die by a process that requires hFis1 expression.
Thus, multiple proteins that comprise the mitochondrial morphogenesis machinery can positively and negatively regulate apoptosis.
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Material and Methods
Cell culture, transfection, DNA constructs and RNA interference (RNAi)
HeLa cells (American Type Culture Collection) were cultured in complete Dulbecco's Modified
Eagle's Medium (DMEM) supplemented with 10% heat-inactivated fetal calf serum, 100 U/ml penicillin and 100 µg/ml streptomycin in 5% CO2 at 37°C. Transfections of HeLa cells were performed using FuGENE 6 (Roche) according to the manufacturer's instructions. The cDNA for hFis1 (GenBank accession number AF151893) was cloned by reverse transcription-PCR with total human RNA as template. cDNA for wild type hFis1 (hFis1wt) and hFis1 lacking the C-terminal 30 residues (hFis1∆C) were cloned into mammalian expression vectors, pcDNA3.1 and pREP4. RNAi was performed using the short hairpin (sh) activated gene silencing system (Paddison et al., 2002) . The plasmids expressing shRNAs were constructed by synthesizing two complementary DNA oligonucleotides bearing the target sequence, HindIII linker and U6
terminator, annealing them and ligating them into BseRI and BamHI sites of pSHAG-1 (Cold Spring Harbor Lab). For long-term (stable) suppression of gene expression by shRNA, the region encoding the U6 promoter and shRNA in pSHAG-1 was subcloned into the Not I and
Bam HI sites of pREP4 (Invitrogen). The target sequences for the hFis1, Opa1 and Drp1 were as follows: 5'-GAGACGCGGGAGCCCACGGAGAACGCTCC -3' for hFis1, 5'-GATGAAGTTATCAGTCTGAGCCAGGTTAC -3' for Opa1. and 5'-TTCAATCCGTGATGAGTATGCTTTTCTTC-3' for Drp1. The sequence for the control shRNA was 5'-TCGTACTCATAATCAGCTCTGCATACATC-3' which targets Opa1 3' end noncoding region and has no effect on silencing of Opa1 gene expression. One day after the transfection with these pREP4 constructs, HeLa cells were grown in DMEM containing 300 µg/ml hygromycin B for 2 days followed by 3-4 days in DMEM containing 50 µg/ml hygromycin B for the selection of transfectants.
Immunocytochemistry and confocal microscopy
Cells grown in 2-well chamber slides were treated as indicated, fixed with 4% paraformaldehyde for 10 min, permeabilized with 0.2% Triton X-100 for 15 min and then blocked with 2% BSA for 1 h at room temperature (RT). Cells were probed with rabbit polyclonal anti-Bax (Upstate, 1:800), mouse monoclonal anti-cytochrome c (BD/Pharmingen, 1:800), or mouse monoclonal anti-DLP1/Drp1 (BD/Transduction, 1:100) overnight at 4°C followed by staining with goat antirabbit Alexa Fluor 594 (Molecular Probes, 1:600) or goat anti-mouse Alexa Fluor 488 antibodies (Molecular Probes, 1:600) for 2 h at RT. After washing, cells were mounted with SlowFade light antifade reagent (Molecular probes) and analyzed by confocal microscopy. In order to visualize the mitochondria in living cells, 50 nM Mitotracker CMXRos (Molecular probes) was added and incubated for 30 min prior to confocal microscopy. To analyze the ∆Ψm, cells were incubated for 20 min with 5 µg/ml JC1 (Molecular probes) in culture medium and observed by confocal microscopy. Images were captured with an LSM 510 Zeiss confocal microscope. Mito-PAGFP-based mitochondrial fusion assay was performed as described previously (Karbowski et al., 2004) 
Subcellular fractionation and immunoblotting
Cells were permeabilized with digitonin (300 µg/ml) in cytosolic extraction buffer (250 mM sucrose, 70 mM KCl, 137 mM NaCl, 4.3 mM Na2HPO4, 1.4 mM KH2PO4, pH 7.2, 100 µM 8 PMSF, 10 µg/ml leupeptin, 2 µg/ml aprotinin) for 5 min on ice. Plasma membrane permeabilization of cells was confirmed by staining cells with trypan blue. Permeabilized cells were centrifuged at 1,000 g for 5 min at 4°C. The supernatants (cytosolic fractions, S) were saved and the pellets were solubilized in the same volume of mitochondrial lysis buffer (50 mM Tris.Cl, pH 7.4, 150 mM NaCl, 2 mM EDTA, 2 mM EGTA, 0.2% Triton X-100, 0.3% NP-40, 100 µM PMSF, 10 µg/ml leupeptin, 2 µg/ml aprotinin), followed by centrifugation at 10,000 g for 10 min at 4°C and the supernatants were used as heavy membrane fractions (HM). Total cell lysates were prepared by solubilizing whole cells in Laemmli sample buffer and boiling them for Blots were detected by ECL Plus (Amersham).
Assessment of apoptotic cell death
By nuclear morphology -Cells grown in chamber slides were treated as mentioned in the text or DNA ladder formation -Cells grown in a 10 cm culture dish were treated as mentioned, harvested, washed once with PBS and total DNA was isolated as described previously (Lee and Shacter, 1997) . After digestion with protenase K and RNase A, the DNA was separated in 2% agarose gels and visualized with ethidium bromide under UV light. By PARP cleavage/caspase-3 activation -PARP is a well known caspase-3 substrate. During apoptosis caspase-3 is activated, so PARP cleavage can be used as a marker of apoptosis. Cells grown in a 10 cm culture dish were treated as described, harvested, and total cell extracts were prepared. Equal amounts of proteins were separated in 4-12% acrylamide gels and immunoblotted with anti-PARP antibodies.
Results

Knock-down of hFis1 or Drp1 expression induces mitochondrial fusion.
Mitochondrial division in yeast requires at least 7-8 proteins (Dimmer et al., 2002) including Dnm1p (Otsuga et al., 1998; Bleazard et al., 1999) and Fis1p (Mozdy et al., 2000; Jakobs et al., 2003) . The deletion or mutation of either of these genes disrupts proper mitochondrial division and causes mitochondrial membranes to form net-like structures (Dimmer et al., 2002) . To explore the roles of the human orthologs of Dnm1p and Fis1p, Drp1 and hFis1, respectively, in mitochondrial fission and apoptosis, we "knocked down" their expression using the short hairpin activated gene silencing system (i.e. SHAGging, Cold Spring Harbor Lab) (Paddison et al., 2002) . In order to generate cell lines that stably suppress the endogenous gene, we transferred the U6-shRNA inserts to pREP4, an episomally-maintained mammalian expression vector with hygromycin as a selective marker.
Among twelve different oligonucleotides designed for hFis1 shRNA, only one, which corresponds to a sequence situated just outside of the 3'-end of the coding sequence, significantly inhibited hFis1 expression in HeLa cells. Selection of transfected HeLa cells with nearly complete depletion of hFis1 required about one week of growth in the presence of hygromycin (Fig. 1A ). More than 70% of these cells had elongated mitochondria, while mitochondria in the remaining cells showed a more normal shape (short tubular) (Fig. 1B,C ).
Normal mitochondria in hFis1 RNAi cells might have been over-scored, considering that hygromycin, which was used for the selection, tends to induce slightly shorter mitochondria (data not shown). Most of the cells which were transfected with a plasmid carrying control shRNA have normal relatively short tubular mitochondria and some fragmented ones, but never elongated mitochondria such as seen in hFis1 shRNA transfectants (Fig. 1B, C ).
Unlike hFis1, four out of six sequences targeted to Drp1 could silence Drp1 gene expression, including one reported previously to be effective in mammalian systems (Koch et al., 2003) . Upon Drp1 depletion ( between dnm1∆ and fis1∆ cells were observed in yeast; both exhibited net-like structures (Mozdy et al., 2000) . However, the larger size of mammalian mitochondria permits better visualization of morphology. Mammalian mitochondria have been reported to display expansions at the ends of mitochondria in cells over-expressing the dominant negative inhibitor, Drp1 K38A (Smirnova et al., 2001 ).
Knock-down of hFis1 did not affect the distribution of Drp1 to mitochondria.
Drp1 is known to distribute predominantly to the cytosol but also accumulates at foci in the mitochondrial outer membrane that represent future fission sites (Labrousse et al., 1999; Smirnova et al., 2001) . Since Drp1 lacks a mitochondrial targeting sequence, some protein(s) may be needed to recruit Drp1 to mitochondria. Human Fis1 is a good candidate for this recruitment since in yeast Fis1p is required for the proper assembly and distribution of Dnm1p-containing complexes on mitochondria (Mozdy et al., 2000; Tieu et al., 2002) and the structure of hFis1 resembles that of certain proteins involved in mitochondrial import (Suzuki et al., 2003) . If this were the case, the mitochondrial distribution of Drp1 should be affected by hFis1-depletion. However, there was little or no difference in the Drp1 distribution between control RNAi cells and hFis1 RNAi cells assessed by immunocytochemistry ( Fig. 2A) or by Western blot analysis of the subcellular-fractionated cytosolic fraction (S) and heavy membrane (HM, mostly mitochondrial fraction) samples (Fig. 2B ). Drp1 is distributed to the mitochondria in hFis1 RNAi cells to a similar extent as in control RNAi cells.
Fis1-depletion produces greater resistance to apoptosis than depletion of Drp1.
Overexpression of the dominant-negative mutant Drp1 K38A induced mitochondrial fusion and cells became resistant to apoptosis (Frank et al., 2001; Karbowski et al., 2002; Breckenridge et al., 2003) , suggesting a close relationship between mitochondrial morphology and sensitivity to cell death. We examined how the knock-down of hFis1 expression affects the sensitivity to cell death by various apoptosis inducers and compared hFis1 RNAi cells to Drp1 RNAi cells. We found that less than 20% of hFis1 RNAi cells were apoptotic under conditions that produced 40-65% apoptosis of control RNAi cells (assessed by apoptotic nuclei) (Fig. 3A) . The caspase-3 activity of hFis1 RNAi cells from STS-, actinomycin D-, or anti-Fas-induced apoptosis was much lower than control RNAi cells assessed by PARP cleavage (Fig. 3B ). Less inhibition of apoptosis by Drp1 silencing was observed (Fig. 3A,B) .
In order to explore the mechanism of the cell death resistance of hFis1 RNAi cells, we examined two early events in apoptosis, the translocation of proapoptotic protein Bax from the cytosol to the mitochondria and the release of cytochrome c from the mitochondria to the cytosol (Kluck et al., 1997; Wolter et al., 1997) . Overexpression of hFis1 wild type (hFis1 wt) but not C-terminus truncated mutant (hFis1 ∆C) reverts the apoptosis-resistant hFis1 RNAi cells.
To confirm that the apoptosis-resistance in hFis1 RNAi cells is the result of hFis1 depletion, we reconstituted hFis1 expression in the hFis1 RNAi cells. The targeted sequence we used for hFis1
RNAi is situated just outside of the 3'-end of the coding sequence, so hFis1 cDNA constructs can be used to express hFis1 in the hFis1 RNAi cells. We cotransfected HeLa cells with cDNA constructs encoding either hFis1 wt or a hFis1∆C mutant lacking the membrane anchor along with the hFis1 shRNAi construct, selected transfectants with hygromycin and examined protein expression levels and sensitivity to apoptosis. As shown in showed more sensitivity to apoptosis than hFis1 RNAi cells assessed by PARP cleavage (Fig.   5A ), nuclei fragmentation ( Fig. 5B ) and cytochrome c release (Figs. 5C,D) . However, the overexpression of hFis1 ∆C mutant in hFis1 RNAi cells did not affect the sensitivity to apoptosis. The results confirm that hFis1 is required for cell sensitivity to apoptosis and show that mitochondrial targeting of hFis1 is necessary for apoptosis promotion.
Knock-down of Opa1 induces mitochondrial fragmentation and sensitizes cells to apoptosis.
The down-regulation of Opa1 in HeLa cells by RNAi was reported to lead to fragmentation of mitochondria, to the dissipation of the mitochondrial membrane potential and to a disorganization of the cristae (Olichon et al., 2003) . These events were followed by cytochrome c release and caspase-dependent apoptotic nuclear events. To study Opa1 function further, especially in conjunction with the fission proteins, hFis1 and Drp1, we designed several shRNA constructs specific to the Opa1 sequence (coding and noncoding) for gene silencing by the same method we used for hFis1 and Drp1 RNAi. The sequence which was reported to down-regulate Opa1 (Olichon et al., 2003) also worked in the SHAGging system. A sequence which did not produce gene silencing was used as a control RNAi. It took 5-7 days after transfection for effective selection of transfectants and Opa1 was almost completely depleted in this population (Fig. 6A ). The lower band, which did not disappear may be a non-specific band rather than one of the eight alternative splicing variants (Delettre et al., 2000) since the targeting sequence we used for RNAi exists in all the splicing variants. Under these conditions almost all the cells displayed extensively fragmented mitochondria, clearly different from the control RNAi cells (Fig. 6B,C) .
In contrast to hFis1 and Drp1 RNAi cells, Opa1 RNAi cells are more sensitive to apoptosis induced by various stimuli compared with the control RNAi cells and, consistent with a previous report (Olichon et al., 2003) , a portion of the cells (25~35%) die spontaneously (Fig. 6D ). Opa1
down-regulated cells die with the typical hallmarks of apoptosis. Nuclear fragmentation (Fig.   6D ), DNA ladder formation (Fig. 6E ), Bax translocation, cytochrome c release (Figs. 6F,G) , and caspase activation/PARP cleavage (Fig. 6H) were all observed. The cell death caused by Opa1-depletion was inhibited by the general caspase inhibitor zVAD-fmk and by Bcl-2 overexpression (data not shown).
Cells depleted of both hFis1 and Opa1 show apoptosis-resistance in spite of extensive mitochondrial fragmentation.
The down-regulation of hFis1 caused extensive mitochondrial fusion and the cells became apoptosis-resistant (Figs. 1,3) . In contrast, Opa1 down-regulation caused extensive mitochondrial fragmentation and cells became more sensitive to death (Fig. 6) . In yeast the elimination of fission mediators can be offset by eliminating fusion mediators (Sesaki and Jensen, 1999; Mozdy et al., 2000; Wong et al., 2000; Sesaki et al., 2003) . Thus, we down regulated both hFis1 and Opa1 and examined the effect on mitochondrial morphology and cell sensitivity to apoptosis.
More than 70% of the cells with both hFis1 and Opa1 almost completely depleted (hFis1/Opa1 RNAi) (Fig. 7A ) displayed fragmented mitochondria (Fig. 7B) , similar to results when cells were treated with Opa1 RNAi alone (Fig. 6B,C) . This may reflect the rate of disappearance of Opa1 and hFis1 over the five-day selection period. Therefore, Fis1 was depleted for 5 days and then Opa1 RNAi was transfected into the Fis1 depleted cells. Examining mitochondrial morphology two days following the Opa1 depletion showed fragmentation of the mitochondria in contrast to cells that expressed control RNAi in the second transfection (Fig.   7C ). Thus, even after depletion of hFis1 with RNAi, a finite rate of mitochondrial fission occurs that becomes predominant in the absence of Opa1. Slower but finite mitochondrial fission also occurs after genetic deletion of Fis1 in yeast (Jakobs et al., 2003) . Residual fission of mitochondria in hFis/Opa1 RNAi was further confirmed by the results obtained using a mitochondrial fusion assay based on the measurement of dilution rates of matrix-targeted photoactivable GFP (mito-PAGFP), as described before (Karbowski et al. 2004) . We found complete inhibition of mitochondria fusion in hFis1/Opa1 double RNAi cells, indistinguishable from that detected in single Opa1 RNAi cells (Fig. 7D, E ).
hFis1/Opa1 RNAi cells were very resistant to apoptosis -almost to the same extent as hFis1 RNAi cells and opposite from Opa1 RNAi cells (Fig. 8A) . However, the degree of the resistance of these cells varied substantially from experiment to experiment (shown by the larger standard error bars in Fig. 8A ). When the hFis1/Opa1 RNAi cells and hFis1 RNAi cells (along with control RNAi cells and Opa1 RNAi cells) were treated longer with anti-Fas antibody, the difference in sensitivity to apoptosis between them became larger (Fig. 8B) . The hFis1/Opa1
RNAi cells are more sensitive than the hFis1 RNAi cells, but never as sensitive as the control RNAi cells or the Opa1 RNAi cells. The resistance of hFis1/Opa1 RNAi cells to apoptosis was also confirmed by inhibition of Act D-induced cytochrome c-release and Bax-translocation (Fig.   8C ). Opa1 is known to be associated with the inner mitochondrial membrane and it has been reported that the depletion of Opa1 caused a loss in mitochondrial membrane potential (Olichon et al., 2003) . Indeed, mitochondrial membrane potential was lost in most of the Opa1-depleted cells, but the loss was prevented by hFis1-co-depletion (Fig. 8D) . Thus, hFis1 is required for both the spontaneous and induced apoptosis caused by loss of Opa1 and functions epistatically to Opa1 in the apoptotic pathway.
Discussion
Mitochondria fragment into smaller and more numerous units when mammalian cells are stimulated to undergo apoptosis (Mancini et al., 1997; De Vos et al., 1998; Zhuang et al., 1998; Desagher et al., 1999; Frank et al., 2001; Karbowski et al., 2002) . When mitochondrial fission is blocked by overexpression of a dominant-negative mutant of Drp1 (Drp1
K38A
) the downstream events of mitochondrial-induced cell death, such as cytochrome c release, are also blocked suggesting that mitochondrial fission might be a required step in apoptosis (Frank et al., 2001; Breckenridge et al., 2003) . Bax, a proapoptotic Bcl-2 family member, colocalizes with Drp1 in mitochondrial foci (Karbowski et al., 2002) . Upon apoptosis initation, Bax translocates from the cytosol to focal structures on the outer membrane of mitochondria (Nechushtan et al., 2001; Valentijn et al., 2003) that become sites of organelle scission (Karbowski et al., 2002) suggesting that Bax may activate the mitochondrial fission machinery.
Screening yeast for mutants that suppress the phenotype of cells lacking the mitochondrial fusion gene, FZO1, led to the initial identification of the importance of the outer mitochondrial membrane protein, Fis1, in mitochondrial fission (Mozdy et al., 2000; Tieu and Nunnari, 2000) .
To further explore the connection between mitochondrial morphology and apoptosis we tested the role in apoptosis of another protein involved in mitochondrial fission, hFis1. Human Fis1 has been reported to induce mitochondrial fragmentation upon overexpression (James et al., 2003; Yoon et al., 2003) and loss of hFis1 induces elongation of mammalian mitochondria (Stojanovski et al., 2004) suggesting a conserved role of FIS1 in eukaryotes. In yeast, FIS1 has been shown genetically to interact with DNM1 and appears to be essential for the recruitment of Dnm1p (Drp1) into focal structures on mitochondria (Mozdy et al., 2000; Tieu et al., 2002) .
Although human Fis1 can be cross-linked to Drp1 (Yoon et al., 2003) , the two do not appear to stably associate (James et al., 2003) nor does overexpression of hFis1 increase Drp1 binding to mitochondria (Suzuki et al., 2003) . Here we further show that, in contrast to yeast, loss of hFis1
does not decrease Drp1 binding to mitochondria (Fig. 2B,C) . However, it is intriguing that hFis1 is required for Bax recruitment into the same, Drp1-containing foci.
We have found that loss of hFis1 inhibits induction of apoptosis. Previously it was reported that overexpression of hFis1 induced cell death that was inhibited by Bcl-xL overexpression (James et al., 2003) . Interestingly, the apoptosis induced by hFis1 overexpression was not inhibited by the dominant negative inhibitor, Drp1 How does hFis1 act as a proapoptotic protein? The hFis1 structure (Suzuki et al., 2003) shows that the protein contains four tandem structures resembling the tetratricopeptide repeat (TPR). The TPR motifs are known to facilitate specific protein-protein interactions (Blatch and Lassle, 1999) , suggesting that hFis1 may bind to other proteins and function as a molecular adaptor (receptor) on the mitochondrial outer membrane. TPR proteins in the outer mitochondrial membrane in addition to hFis1 include Tom20 (Iwahashi et al., 1997) and Tom70 (Young et al., 2003) , both of which are involved in recruitment of other proteins to mitochondria. Although hFis1 does not appear to recruit Drp1 to mitochondria, a number of other interesting candidates will be worth examining. The notable differences between yeast and human mitochondrial fission and fusion machinery may offer insights into apoptosis as well as the mechanism of mitochondrial biogenesis.
Loss of a protein involved in mitochondrial fusion had the opposite effect on apoptosis from the loss of two proteins involved in mitochondrial fission. When Opa1 was depleted by RNAi, the mitochondria were extensively fragmented and cells became very sensitive to apoptosis, consistent with the results reported by others (Olichon et al., 2003; Griparic et al., 2004) , and further correlating mitochondrial fragmentation with sensitivity to apoptosis. Our 
